Molecular diagnosis utility of multiplex ligation-dependent probe amplification

Bibliography

• Freeman JL, Perry GH, Feuk L, et al. Copy number variation: New insights in genome diversity. Genome Res 2006;16:949-61
   PubMed Web of Science ®Google Scholar
• Gatta V, Scarciolla O, Gaspari AR, et al. Identification of deletions and duplications of the DMD gene in affected males and carrier females by multiple ligation probe amplification (MLPA). Hum Genet 2005;117(1):92-8
   PubMed Web of Science ®Google Scholar
• Janssen B, Hartmann C, Scholz V, et al. MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls. Neurogenetics 2005;6(1):29-35
   PubMed Web of Science ®Google Scholar
• Lai KK, Lo IF, Tong TM, et al. Detecting exon deletions and duplications of the DMD gene using Multiplex Ligation-dependent Probe Amplification (MLPA). Clin Biochem 2006;39(4):367-72
   PubMed Web of Science ®Google Scholar
• White SJ, den Dunnen JT. Copy number variation in the genome; the human DMD gene as an example. Cytogenet Genome Res 2006;115(3-4):240-6
   PubMed Web of Science ®Google Scholar
• Baudhuin LM, Mai M, French AJ, et al. Analysis of hMLH1 and hMSH2 gene dosage alterations in hereditary nonpolyposis colorectal cancer patients by novel methods. J Mol Diagn 2005;7(2):226-35
   PubMed Web of Science ®Google Scholar
• Bunyan DJ, Eccles DM, Sillibourne J, et al. Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 2004;91(6):1155-9
   PubMed Web of Science ®Google Scholar
• Taylor CF, Charlton RS, Burn J, et al. Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA. Hum Mutat 2003;22(6):428-33
   PubMed Web of Science ®Google Scholar
• Wehner M, Mangold E, Sengteller M, et al. Hereditary nonpolyposis colorectal cancer: pitfalls in deletion screening in MSH2 and MLH1 genes. Eur J Hum Genet 2005;13(8):983-6
   PubMed Web of Science ®Google Scholar
• Sellner LN, Taylor GR. MLPA and MAPH: new techniques for detection of gene deletions. Hum Mutat 2004;23(5):413-9
   PubMed Web of Science ®Google Scholar
• White SJ, Breuning MH, den Dunnen JT. Detecting copy number changes in genomic DNA: MAPH and MLPA. Methods Cell Biol 2004;75:751-68
   PubMed Web of Science ®Google Scholar
• Alibakhshi R, Kianishirazi R, Cassiman JJ, et al. Analysis of the CFTR gene in Iranian cystic fibrosis patients: Identification of eight novel mutations. J Cyst Fibros 2007
   PubMedGoogle Scholar
• Hantash FM, Milunsky A, Wang Z, et al. A large deletion in the CFTR gene in CBAVD. Genet Med 2006;8(2):93-5
   PubMed Web of Science ®Google Scholar
• Hantash FM, Redman JB, Goos D, et al. Characterization of a recurrent novel large duplication in the cystic fibrosis transmembrane conductance regulator gene. J Mol Diagn 2007;9(4):556-60
   PubMed Web of Science ®Google Scholar
• Schneider M, Joncourt F, Sanz J, et al. Detection of exon deletions within an entire gene (CFTR) by relative quantification on the LightCycler. Clin Chem 2006;52(11):2005-12
   PubMed Web of Science ®Google Scholar
• Prigoda NL, Savas S, Abdalla SA, et al. Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations. J Med Genet 2006;43(9):722-8
   PubMed Web of Science ®Google Scholar
• Bayrak-Toydemir P, McDonald J, Markewitz B, et al. Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations. Am J Med Genet A 2006;140(5):463-70
   PubMed Web of Science ®Google Scholar
• Gedge F, McDonald J, Phansalkar A, et al. Clinical and analytical sensitivities in hereditary hemorrhagic telangiectasia testing and a report of de novo mutations. J Mol Diagn 2007;9(2):258-65
   PubMed Web of Science ®Google Scholar
• Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002;30(12):e57
   PubMed Web of Science ®Google Scholar
• Procter M, Chou LS, Tang W, et al. Molecular diagnosis of Prader-Willi and Angelman syndromes by methylation-specific melting analysis and methylation-specific multiplex ligation-dependent probe amplification. Clin Chem 2006;52(7):1276-83
   PubMed Web of Science ®Google Scholar
• Nygren AO, Ameziane N, Duarte HM, et al. Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res 2005;33(14):e128
   PubMed Web of Science ®Google Scholar
• Hwa HL, Chang YY, Chen CH, et al. Multiplex ligation-dependent probe amplification identification of deletions and duplications of the Duchenne muscular dystrophy gene in Taiwanese subjects. J Formos Med Assoc 2007;106(5):339-46
   PubMed Web of Science ®Google Scholar
• Lalic T, Vossen RH, Coffa J, et al. Deletion and duplication screening in the DMD gene using MLPA. Eur J Hum Genet 2005;13(11):1231-4
   PubMed Web of Science ®Google Scholar
• Akrami SM, Dunlop MG, Farrington SM, et al. Screening for exonic copy number mutations at MSH2 and MLH1 by MAPH. Fam Cancer 2005;4(2):145-9
   PubMed Web of Science ®Google Scholar
• Castellvi-Bel S, Castells A, Strunk M, et al. Genomic rearrangements in MSH2 and MLH1 are rare mutational events in Spanish patients with hereditary nonpolyposis colorectal cancer. Cancer Lett 2005;225(1):93-8
   PubMed Web of Science ®Google Scholar
• Grabowski M, Mueller-Koch Y, Grasbon-Frodl E, et al. Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families. Genet Test 2005;9(2):138-46
   PubMedGoogle Scholar
• Kluwe L, Nygren AO, Errami A, et al. Screening for large mutations of the NF2 gene. Genes Chromosomes Cancer 2005;42(4):384-91
   PubMed Web of Science ®Google Scholar
• Spurlock G, Griffiths S, Uff J, Upadhyaya M. Somatic alterations of the NF1 gene in an NF1 individual with multiple benign tumours (internal and external) and malignant tumour types. Fam Cancer 2007;6(4):463-71
   PubMed Web of Science ®Google Scholar
• Wimmer K, Yao S, Claes K, et al. Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients. Genes Chromosomes Cancer 2006;45(3):265-76
   PubMed Web of Science ®Google Scholar
• Dikow N, Nygren AO, Schouten JP, et al. Quantification of the methylation status of the PWS/AS imprinted region: comparison of two approaches based on bisulfite sequencing and methylation-sensitive MLPA. Mol Cell Probes 2007;21(3):208-15
   PubMed Web of Science ®Google Scholar
• Hogervorst FB, Nederlof PM, Gille JJ, et al. Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 2003;63(7):1449-53
   PubMed Web of Science ®Google Scholar
• MRC-Holland. Software packages available for MLPA analysis. 2005. Available from: http://www.mlpa.com/pages/indexpag.html [Last accessed 5 February 2008]
   Google Scholar
• Hollox EJ, Akrami SM, Armour JA. DNA copy number analysis by MAPH: molecular diagnostic applications. Expert Rev Mol Diagn 2002;2(4):370-8
   PubMedGoogle Scholar
• Montagna M, Dalla Palma M, Menin C, et al. Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 2003;12(9):1055-61
   PubMed Web of Science ®Google Scholar
• Rooms L, Reyniers E, van Luijk R, et al. Subtelomeric deletions detected in patients with idiopathic mental retardation using multiplex ligation-dependent probe amplification (MLPA). Hum Mutat 2004;23(1):17-21
   PubMed Web of Science ®Google Scholar
• Palomares M, Delicado A, Lapunzina P, et al. MLPA vs multiprobe FISH: comparison of two methods for the screening of subtelomeric rearrangements in 50 patients with idiopathic mental retardation. Clin Genet 2006;69(3):228-33
   PubMed Web of Science ®Google Scholar
• Gutierrez-Enriquez S, de la Hoya M, Martinez-Bouzas C, et al. Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer. Breast Cancer Res Treat 2007;103(1):103-7
   PubMed Web of Science ®Google Scholar
• Lim YK, Lau PT, Ali AB, et al. Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer. Clin Genet 2007;71(4):331-42
   PubMed Web of Science ®Google Scholar
• Purnomosari D, Aryandono T, Setiaji K, et al. Comparison of multiplex ligation dependent probe amplification to immunohistochemistry for assessing HER-2/neu amplification in invasive breast cancer. Biotech Histochem 2006;81(2-3):79-85
   PubMed Web of Science ®Google Scholar
• Purnomosari D, Pals G, Wahyono A, et al. BRCA1 and BRCA2 germline mutation analysis in the Indonesian population. Breast Cancer Res Treat 2007;106(2):297-304
   PubMed Web of Science ®Google Scholar
• Vasickova P, Machackova E, Lukesova M, et al. High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic. BMC Med Genet 2007;8:32
   PubMedGoogle Scholar
• Moerland E, van Hezik RL, van der Aa TC, et al. Detection of HER2 amplification in breast carcinomas: comparison of Multiplex Ligation-dependent Probe Amplification (MLPA) and Fluorescence In Situ Hybridization (FISH) combined with automated spot counting. Cell Oncol 2006;28(4):151-9
   PubMedGoogle Scholar
• Slater H, Bruno D, Ren H, et al. Improved testing for CMT1A and HNPP using multiplex ligation-dependent probe amplification (MLPA) with rapid DNA preparations: comparison with the interphase FISH method. Hum Mutat 2004;24(2):164-71
   PubMed Web of Science ®Google Scholar
• Begbie ME, Wallace GM, Shovlin CL. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J 2003;79(927):18-24
   PubMed Web of Science ®Google Scholar
• Scala E, Longo I, Ottimo F, et al. MECP2 deletions and genotype-phenotype correlation in Rett syndrome. Am J Med Genet A 2007;143(23):2775-84
   Google Scholar
• Ravn K, Nielsen JB, Skjeldal OH, et al. Large genomic rearrangements in MECP2. Hum Mutat 2005;25(3):324
   PubMedGoogle Scholar
• Scarciolla O, Stuppia L, De Angelis MV, et al. Spinal muscular atrophy genotyping by gene dosage using multiple ligation-dependent probe amplification. Neurogenetics 2006;7(4):269-76
   PubMed Web of Science ®Google Scholar
• Zielenski J, O'Brien A, Tsui L. Cystic Fibrosis Mutation Database. 2007. Available from: http://www.genet.sickkids.on.ca/cftr/app [Last updated 2 March 2007], [Last accessed 5 February 2008]
   Google Scholar
• Schneider M, Hirt C, Casaulta C, et al. Large deletions in the CFTR gene: clinics and genetics in Swiss patients with CF. Clin Genet 2007;72(1):30-8
   PubMed Web of Science ®Google Scholar
• Jaenisch R. DNA methylation and imprinting: why bother? Trends Genet 1997;13(8):323-9
   PubMed Web of Science ®Google Scholar
• Paulsen M, Ferguson-Smith AC. DNA methylation in genomic imprinting, development, and disease. J Pathol 2001;195(1):97-110
   PubMed Web of Science ®Google Scholar
• Razin A, Riggs AD. DNA methylation and gene function. Science 1980;210(4470):604-10
   PubMed Web of Science ®Google Scholar
• Takada S, Tevendale M, Baker J, et al. Delta-like and gtl2 are reciprocally expressed, differentially methylated linked imprinted genes on mouse chromosome 12. Curr Biol 2000;10(18):1135-8
   PubMed Web of Science ®Google Scholar
• Eads CA, Laird PW. Combined bisulfite restriction analysis (COBRA). Methods Mol Biol 2002;200:71-85
   PubMedGoogle Scholar
• Xiong Z, Laird PW. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997;25(12):2532-4
   PubMed Web of Science ®Google Scholar
• Baumer A, Wiedemann U, Hergersberg M, Schinzel A. A novel MSP/DHPLC method for the investigation of the methylation status of imprinted genes enables the molecular detection of low cell mosaicisms. Hum Mutat 2001;17(5):423-30
   PubMed Web of Science ®Google Scholar
• Betz B, Florl AR, Seifert HH, et al. Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancer. Hum Mutat 2004;23(6):612-20
   PubMed Web of Science ®Google Scholar
• Couvert P, Poirier K, Carrie A, et al. DHPLC-based method for DNA methylation analysis of differential methylated regions from imprinted genes. Biotechniques 2003;34(2):356-62
   PubMed Web of Science ®Google Scholar
• Deng D, Deng G, Lu Y. Analysis of the methylation in CpG island by denaturing high-performance liquid chromatography. Zhonghua Yi Xue Za Zhi 2001;81(3):158-61
   PubMedGoogle Scholar
• Deng D, Deng G, Smith MF, et al. Simultaneous detection of CpG methylation and single nucleotide polymorphism by denaturing high performance liquid chromatography. Nucleic Acids Res 2002;30(3):E13
   Google Scholar
• Perry AS, Liyanage H, Lawler M, Woodson K. Discovery of DNA hypermethylation using a DHPLC screening strategy. Epigenetics 2007;2(1):43-9
   PubMedGoogle Scholar
• Frevel MA, Sowerby SJ, Petersen GB, Reeve AE. Methylation sequencing analysis refines the region of H19 epimutation in Wilms tumor. J Biol Chem 1999;274(41):29331-40
   PubMed Web of Science ®Google Scholar
• Hajkova P, el-Maarri O, Engemann S, et al. DNA-methylation analysis by the bisulfite-assisted genomic sequencing method. Methods Mol Biol 2002;200:143-54
   PubMedGoogle Scholar
• Han W, Cauchi S, Herman JG, Spivack SD. DNA methylation mapping by tag-modified bisulfite genomic sequencing. Anal Biochem 2006;355(1):50-61
   PubMed Web of Science ®Google Scholar
• Kammer C, Doerfler W. Genomic sequencing reveals absence of DNA methylation in the major late promoter of adenovirus type 2 DNA in the virion and in productively infected cells. FEBS Lett 1995;362(3):301-5
   PubMed Web of Science ®Google Scholar
• MacKay DJ, Temple IK, Shield JP, Robinson DO. Bisulphite sequencing of the transient neonatal diabetes mellitus DMR facilitates a novel diagnostic test but reveals no methylation anomalies in patients of unknown aetiology. Hum Genet 2005;116(4):255-61
   PubMed Web of Science ®Google Scholar
• McDonald LE, Kay GF. Methylation analysis using bisulfite genomic sequencing: application to small numbers of intact cells. Biotechniques 1997;22(2):272-4
   PubMed Web of Science ®Google Scholar
• Szabo PE, Mann JR, Pfeifer GP. Methylation analysis by chemical DNA sequencing. Methods Mol Biol 2002;200:29-41
   PubMedGoogle Scholar
• Taylor KH, Kramer RS, Davis JW, et al. Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res 2007;67(18):8511-8
   PubMed Web of Science ®Google Scholar
• White HE, Hall VJ, Cross NC. Methylation-sensitive high-resolution melting-curve analysis of the SNRPN gene as a diagnostic screen for Prader-Willi and Angelman syndromes. Clin Chem 2007;53(11):1960-2
   PubMed Web of Science ®Google Scholar
• Worm J, Aggerholm A, Guldberg P. In-tube DNA methylation profiling by fluorescence melting curve analysis. Clin Chem 2001;47(7):1183-9
   PubMed Web of Science ®Google Scholar
• Gonzalgo ML, Liang G. Methylation-sensitive single-nucleotide primer extension (Ms-SNuPE) for quantitative measurement of DNA methylation. Nat Protoc 2007;2(8):1931-6
   PubMed Web of Science ®Google Scholar
• El-Maarri O. SIRPH analysis: SNuPE with IP-RP-HPLC for quantitative measurements of DNA methylation at specific CpG sites. Methods Mol Biol 2004;287:195-205
   PubMedGoogle Scholar
• El-Maarri O, Herbiniaux U, Walter J, Oldenburg J. A rapid, quantitative, non-radioactive bisulfite-SNuPE-IP RP HPLC assay for methylation analysis at specific CpG sites. Nucleic Acids Res 2002;30(6):e25
   PubMed Web of Science ®Google Scholar
• Gao L, Cheng L, Zhou JN, et al. DNA microarray: a high throughput approach for methylation detection. Coll Surf B Biointerfaces 2005;40(3-4):127-31
   PubMed Web of Science ®Google Scholar
• Gitan RS, Shi H, Chen CM, et al. Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. Genome Res 2002;12(1):158-64
   PubMed Web of Science ®Google Scholar
• Shi H, Maier S, Nimmrich I, et al. Oligonucleotide-based microarray for DNA methylation analysis: principles and applications. J Cell Biochem 2003;88(1):138-43
   PubMed Web of Science ®Google Scholar
• Wei SH, Chen CM, Strathdee G, et al. Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers. Clin Cancer Res 2002;8(7):2246-52
   PubMed Web of Science ®Google Scholar
• Yamamoto F, Yamamoto M. A DNA microarray-based methylation-sensitive (MS)-AFLP hybridization method for genetic and epigenetic analyses. Mol Genet Genomics 2004;271(6):678-86
   PubMed Web of Science ®Google Scholar
• Yan PS, Wei SH, Huang TH. Methylation-specific oligonucleotide microarray. Methods Mol Biol 2004;287:251-60
   PubMedGoogle Scholar
• Jeuken JW, Cornelissen SJ, Vriezen M, et al. MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas. Lab Invest 2007;87(10):1055-65
   PubMed Web of Science ®Google Scholar
• Scott RH, Douglas J, Baskcomb L, et al. Methylation-specific MLPA (MS-MLPA) robustly detects and distinguishes 11p15 abnormalities associated with overgrowth and growth retardation. J Med Genet 2008;45(2):106-13
   PubMed Web of Science ®Google Scholar
• Stern RF, Roberts RG, Mann K, et al. Multiplex ligation-dependent probe amplification using a completely synthetic probe set. Biotechniques 2004;37(3):399-405
   PubMed Web of Science ®Google Scholar
• Benn PA. Advances in prenatal screening for Down syndrome. I. General principles and second trimester testing. Clin Chim Acta 2002;323(1-2):1-16
   PubMed Web of Science ®Google Scholar
• Hochstenbach R, Meijer J, van de Brug J, et al. Rapid detection of chromosomal aneuploidies in uncultured amniocytes by multiplex ligation-dependent probe amplification (MLPA). Prenat Diagn 2005;25(11):1032-9
   PubMed Web of Science ®Google Scholar
• Nicolaides KH, Bindra R, Heath V, Cicero S. One-stop clinic for assessment of risk of chromosomal defects at 12 weeks of gestation. J Matern Fetal Neonatal Med 2002;12(1):9-18
   PubMedGoogle Scholar
• Hulten MA, Dhanjal S, Pertl B. Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCR. Reproduction 2003;126(3):279-97
   PubMed Web of Science ®Google Scholar
• Gerdes T, Kirchhoff M, Lind AM, et al. Computer-assisted prenatal aneuploidy screening for chromosome 13, 18, 21, X and Y based on multiplex ligation-dependent probe amplification (MLPA). Eur J Hum Genet 2005;13(2):171-5
   PubMed Web of Science ®Google Scholar
• Slater HR, Bruno DL, Ren H, et al. Rapid, high throughput prenatal detection of aneuploidy using a novel quantitative method (MLPA). J Med Genet 2003;40(12):907-12
   PubMed Web of Science ®Google Scholar
• Knight SJ, Regan R, Nicod A, et al. Subtle chromosomal rearrangements in children with unexplained mental retardation. Lancet 1999;354(9191):1676-81
   PubMed Web of Science ®Google Scholar
• Knight SJ, Flint J. Perfect endings: a review of subtelomeric probes and their use in clinical diagnosis. J Med Genet 2000;37(6):401-9
   PubMed Web of Science ®Google Scholar
• Koolen DA, Nillesen WM, Versteeg MH, et al. Screening for subtelomeric rearrangements in 210 patients with unexplained mental retardation using multiplex ligation dependent probe amplification (MLPA). J Med Genet 2004;41(12):892-9
   PubMed Web of Science ®Google Scholar
• Ahn JW, Ogilvie CM, Welch A, et al. Detection of subtelomere imbalance using MLPA: validation, development of an analysis protocol, and application in a diagnostic centre. BMC Med Genet 2007;8:9
   PubMedGoogle Scholar
• Bruno DL, Burgess T, Ren H, et al. High-throughput analysis of chromosome abnormality in spontaneous miscarriage using an MLPA subtelomere assay with an ancillary FISH test for polyploidy. Am J Med Genet A 2006;140(24):2786-93
   PubMed Web of Science ®Google Scholar
• Stewart DR, Kleefstra T. The chromosome 9q subtelomere deletion syndrome. Am J Med Genet C Semin Med Genet 2007;145(4):383-92
   Google Scholar
• Rimoin D, Connor J, Pyeritz R, Korf B. Principal and Practice of Medical Genetics. IV edition. Philadelphia: Churchill Livingstone Elsevier; 2007
   Google Scholar
• Jalali GR, Vorstman JA, Errami A, et al. Detailed analysis of 22q11.2 with a high density MLPA probe set. Hum Mutat 2008;29(3):433-40
   PubMed Web of Science ®Google Scholar
• Stachon AC, Baskin B, Smith AC, et al. Molecular diagnosis of 22q11.2 deletion and duplication by multiplex ligation dependent probe amplification. Am J Med Genet A 2007
   PubMedGoogle Scholar
• Kirchhoff M, Bisgaard AM, Bryndorf T, Gerdes T. MLPA analysis for a panel of syndromes with mental retardation reveals imbalances in 5.8% of patients with mental retardation and dysmorphic features, including duplications of the Sotos syndrome and Williams-Beuren syndrome regions. Eur J Med Genet 2007;50(1):33-42
   PubMed Web of Science ®Google Scholar
• Poot M, Kroes HY, VD Wijst SE, et al. Dandy-Walker complex in a boy with a 5 Mb deletion of region 1q44 due to a paternal t(1;20)(q44;q13.33). Am J Med Genet A 2007;143(10):1038-44
   Google Scholar
• Lundquist P, Flynn G, Thorland E, Dawson D. Detection of chromosome 18q11-12 microdeletions in two Niemann-Pick type C families using luminex-based MLPA and FISH. J Mol Diagn 2005;7(5):657-8
   Google Scholar
• Courteau L, Lndquist P, Ensenauer R, et al. Detection of chromosome 22q11duplications using FlexMAPTM microspheres and MLPA. J Mol Diagn 2005;7:658
   Google Scholar
• Chou LS, Sumner K, Lyon E. A practical approach: multiplex ligation-dependent probe amplification (MLPA) analysis of deletions/duplications in CFTR gene using whole genome amplification (WGA). Poster: American Society of Human Genetics; 2007
   Google Scholar
• de Bustos C, Diaz de Stahl T, Piotrowski A, et al. Analysis of copy number variation in the normal human population within a region containing complex segmental duplications on 22q11 using high-resolution array-CGH. Genomics 2006;88(2):152-62
   PubMed Web of Science ®Google Scholar
• de Smith AJ, Tsalenko A, Sampas N, et al. Array CGH analysis of copy number variation identifies 1284 new genes variant in healthy white males: implications for association studies of complex diseases. Hum Mol Genet 2007;16(23):2783-94
   PubMed Web of Science ®Google Scholar
• Lai Y, Zhao H. A statistical method to detect chromosomal regions with DNA copy number alterations using SNP-array-based CGH data. Comput Biol Chem 2005;29(1):47-54
   PubMed Web of Science ®Google Scholar
• Liu W, Chang B, Sauvageot J, et al. Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array. Genes Chromosomes Cancer 2006;45(11):1018-32
   PubMed Web of Science ®Google Scholar
• Yano S, Matsuyama H, Matsuda K, et al. Accuracy of an array comparative genomic hybridization (CGH) technique in detecting DNA copy number aberrations: comparison with conventional CGH and loss of heterozygosity analysis in prostate cancer. Cancer Genet Cytogenet 2004;150(2):122-7
   PubMed Web of Science ®Google Scholar
• Zhou X, Mok SC, Chen Z, et al. Concurrent analysis of loss of heterozygosity (LOH) and copy number abnormality (CNA) for oral premalignancy progression using the Affymetrix 10K SNP mapping array. Hum Genet 2004;115(4):327-30
   PubMed Web of Science ®Google Scholar
• Zeng F, Ren ZR, Huang SZ, et al. Array-MLPA: comprehensive detection of deletions and duplications and its application to DMD patients. Hum Mutat 2007
   Google Scholar